Sergio Traversa
Chief Executive Officer chez RELMADA THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Sergio Traversa was the founder of Medeor, Inc. (founded in 2010) where he served as the Chief Executive Officer from 2010 to 2011.
He is currently the Chief Executive Officer & Director at Relmada Therapeutics, Inc. since 2019.
Dr. Traversa had also held former positions as the President, Chief Executive Officer, CFO & Director at Cactus Ventures, Inc. from 2012 to 2013, Chief Executive Officer & Director at Camp Nine, Inc., Chief Executive Officer at Relmada Therapeutics, Inc. from 2012 to 2013, Chief Executive Officer at Medeor, Inc. from 2010 to 2012, Director at Actinium Pharmaceuticals, Inc., and Managing Director at ING Barings LLC.
Additionally, he served as an Independent Director at Actinium Pharmaceuticals, Inc. from 2013 to 2017.
Dr. Traversa has a background in marketing and sales, having worked as a Marketing Manager-Hospital Business Unit at Eli Lilly & Co., Area Manager-Southern Europe at Therakos, Inc., and Head-Sales at Farmitalia Carlo Erba Ltd.
He holds an undergraduate degree from the University of Turin and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC
0,81% | 27/03/2024 | 244 024 ( 0,81% ) | 1 M $ | 31/03/2024 |
Postes actifs de Sergio Traversa
| Sociétés | Poste | Début |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Executive Officer | 01/04/2012 |
Anciens postes connus de Sergio Traversa
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 16/09/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Chief Executive Officer | 18/04/2013 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Director/Board Member | 18/04/2013 |
| Medeor, Inc. | Chief Executive Officer | 01/04/2012 |
| Farmitalia Carlo Erba Ltd. | Sales & Marketing | - |
Formation de Sergio Traversa
| University of Turin | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| RELMADA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Health Technology |
Therakos, Inc.
 Therakos, Inc. Medical/Nursing ServicesHealth Services Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Health Services |
| ING Barings LLC | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
| Farmitalia Carlo Erba SRL | Health Technology |
Ardana Capital Management LP
 Ardana Capital Management LP Investment ManagersFinance Founded in 2007, Ardana Capital Management LP is a hedge fund manager located in New York City | Finance |
| Medeor, Inc. | |
| Farmitalia Carlo Erba Ltd. |
